| Name | Title | Contact Details |
|---|
alpha electric inc is a Sterling Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BIO 101 is a Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Acuity Healthcare is an employee-owned Long Term Acute Care (LTAC) hospital company, founded in 2001. Acuity is the only company with the flexibility to tailor its services to meet the specific needs of its clients. We understand how LTAC services can, and should work, within today`s "post-acute continuum". This innate flexibility and core understanding of the complexities of the healthcare continuum has enabled Acuity to develop a broad array of services that include: Joint Ventured ownership of its LTAC hospitals with area physicians and local hospitals, full LTAC contract management services, full LTAC contract financial management services and complete LTAC consulting services.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
OM1 is a leading health outcomes and registries company focused on the measurement, comparison, and prediction of treatment outcomes. Leveraging big data, standardized outcomes measurement, and artificial intelligence technology, OM1 built the first intelligent data cloud for healthcare, enabling more precise information and better decision making for stakeholders across the healthcare ecosystem.